Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mydecine Innovations Group Inc (MYCO.NE)

Mydecine Innovations Group Inc (MYCO.NE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NEO]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NEO]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 3,966
  • Shares Outstanding, K 5,219
  • Annual Sales, $ 7 K
  • Annual Income, $ -28,897 K
  • 60-Month Beta 4.32
  • Price/Sales 541.14
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MYCO.NE with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.660 +24.24%
on 06/22/22
1.050 -21.90%
on 06/16/22
-0.180 (-18.00%)
since 05/30/22
3-Month
0.660 +24.24%
on 06/22/22
4.750 -82.74%
on 04/05/22
-3.930 (-82.74%)
since 03/30/22
52-Week
0.660 +24.24%
on 06/22/22
30.000 -97.27%
on 07/13/21
-18.180 (-95.68%)
since 06/30/21

Most Recent Stories

More News
U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
MYCOF : 0.6400 (-8.57%)
Mydecine Provides Company Update; Welcomes New Board Member

DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
MYCOF : 0.6400 (-8.57%)
Mydecine Announces First Quarter 2022 Financial Results and Highlights

DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
MYCOF : 0.6400 (-8.57%)
American Billionaire Entrepreneurs Bet Millions on Psychedelics

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...

CYBN.NE : 0.720 (+2.13%)
MYCO.NE : 0.820 (+2.50%)
PYPL : 69.84 (-2.28%)
TSLA : 673.42 (-1.76%)
CYBN : 0.5600 (+0.13%)
MYCOF : 0.6400 (-8.57%)
NUMI.TO : 0.2450 (+2.08%)
NUMIF : 0.1854 (+3.00%)
ATAI : 3.64 (-1.09%)
ENVB : 0.2143 (-9.58%)
Why Psychedelics Could Soon Replace Antidepressants

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...

CYBN.NE : 0.720 (+2.13%)
MMED.NE : 0.820 (-5.75%)
MYCO.NE : 0.820 (+2.50%)
SEEL : 0.6803 (-1.92%)
MNMD : 0.6401 (-4.03%)
CMPS : 10.82 (+4.44%)
MYCOF : 0.6400 (-8.57%)
CYBN : 0.5600 (+0.13%)
Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides a Business Update

MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval Company Advances IP Portfolio With New Patent Applications...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
Demand for Toad Venom Rises Along With the Booming Psychedelics Market

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – March 30, 2022 –  Depression and anxiety affect millions around the world and the venom of a toad is the latest  psychedelic...

MMED.NE : 0.820 (-5.75%)
MYCO.NE : 0.820 (+2.50%)
NUMI.TO : 0.2450 (+2.08%)
NUMIF : 0.1854 (+3.00%)
SEEL : 0.6803 (-1.92%)
MNMD : 0.6401 (-4.03%)
MYCOF : 0.6400 (-8.57%)
CMPS : 10.82 (+4.44%)
Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

Clinical trial programs advance to further assess psychedelic-assisted psychotherapy utilizing lead drug candidate MYCO-001...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
MYCOF : 0.6400 (-8.57%)
Mydecine To Attend March Investor Conferences

Learn more about Mydecine’s clinical trials and drug development strategy by scheduling a meeting with management...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
MYCOF : 0.6400 (-8.57%)
Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study

Company rapidly prepares to submit IND and Breakthrough Therapy Status Applications ...

MYCO.NE : 0.820 (+2.50%)
OTC.VN : 0.375 (+1.35%)
MYCOF : 0.6400 (-8.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.060
2nd Resistance Point 0.980
1st Resistance Point 0.900
Last Price 0.820
1st Support Level 0.740
2nd Support Level 0.660
3rd Support Level 0.580

See More

52-Week High 30.000
Fibonacci 61.8% 18.792
Fibonacci 50% 15.330
Fibonacci 38.2% 11.868
Last Price 0.820
52-Week Low 0.660

See More

Business Summary

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses:...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar